Trial · NCT03029208
Results by group295
Each measurement the trial posted, group by group, in the words and numbers it posted.
1 to 20 of 295
Download this page as JSON| Outcome | Group | Category | Value | Spread | Units |
|---|---|---|---|---|---|
| Mean Change From Baseline in Hemoglobin (Hgb) During Evaluation Period (Week 28 to Week 52) | Daprodustat | 1.02 | Standard Error 0.086 | Grams per deciliter | |
| Mean Change From Baseline in Hemoglobin (Hgb) During Evaluation Period (Week 28 to Week 52) | Darbepoetin Alfa | 1.12 | Standard Error 0.085 | Grams per deciliter | |
| Average Monthly Intravenous Iron Dose (Milligrams) From Baseline to Week 52 | Daprodustat | 144.7 | Standard Error 10.90 | Milligram | |
| Average Monthly Intravenous Iron Dose (Milligrams) From Baseline to Week 52 | Darbepoetin Alfa | 125.3 | Standard Error 10.97 | Milligram | |
| Change From Baseline in Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Mean Arterial Blood Pressure (MAP) at Week 52 | Daprodustat | SBP | -3.57 | Standard Error 2.063 | Millimeter of mercury |
| Change From Baseline in Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Mean Arterial Blood Pressure (MAP) at Week 52 | Darbepoetin Alfa | SBP | -6.80 | Standard Error 2.931 | Millimeter of mercury |
| Change From Baseline in Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Mean Arterial Blood Pressure (MAP) at Week 52 | Daprodustat | DBP | 0.21 | Standard Error 1.216 | Millimeter of mercury |
| Change From Baseline in Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Mean Arterial Blood Pressure (MAP) at Week 52 | Darbepoetin Alfa | DBP | -4.01 | Standard Error 1.650 | Millimeter of mercury |
| Change From Baseline in Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Mean Arterial Blood Pressure (MAP) at Week 52 | Daprodustat | MAP | -0.95 | Standard Error 1.364 | Millimeter of mercury |
| Change From Baseline in Systolic Blood Pressure (SBP), Diastolic Blood Pressure (DBP), Mean Arterial Blood Pressure (MAP) at Week 52 | Darbepoetin Alfa | MAP | -5.05 | Standard Error 1.894 | Millimeter of mercury |
| Change From Baseline in SBP, DBP, MAP at End of Treatment | Daprodustat | SBP | -3.23 | Standard Error 1.659 | Millimeter of mercury |
| Change From Baseline in SBP, DBP, MAP at End of Treatment | Darbepoetin Alfa | SBP | -3.14 | Standard Error 1.664 | Millimeter of mercury |
| Change From Baseline in SBP, DBP, MAP at End of Treatment | Daprodustat | DBP | 0.60 | Standard Error 1.016 | Millimeter of mercury |
| Change From Baseline in SBP, DBP, MAP at End of Treatment | Darbepoetin Alfa | DBP | -1.39 | Standard Error 1.020 | Millimeter of mercury |
| Change From Baseline in SBP, DBP, MAP at End of Treatment | Daprodustat | MAP | -0.68 | Standard Error 1.092 | Millimeter of mercury |
| Change From Baseline in SBP, DBP, MAP at End of Treatment | Darbepoetin Alfa | MAP | -1.97 | Standard Error 1.096 | Millimeter of mercury |
| Blood Pressure (BP) Exacerbation Events Rate Per 100 Participant Years | Daprodustat | 352.50 | 95% Confidence Interval 268.89 to 462.09 | Events per 100 participant year | |
| Blood Pressure (BP) Exacerbation Events Rate Per 100 Participant Years | Darbepoetin Alfa | 350.00 | 95% Confidence Interval 267.72 to 457.56 | Events per 100 participant year | |
| Number of Participants With at Least One Blood Pressure Exacerbation Event During Study | Daprodustat | 91 | Participants | ||
| Number of Participants With at Least One Blood Pressure Exacerbation Event During Study | Darbepoetin Alfa | 100 | Participants |
Source ClinicalTrials.govtrials-2026-11-12-0.5.0
Sources 3
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ClinicalTrials.govNo license stated
- NIH RePORTER's clinical studies and project filesPublic domain
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ClinicalTrials.govnone stated
- NIH RePORTER's clinical studies and project filesPublic domain (NIH RePORTER)
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/trials/v1/NCT03029208/results